Table 6.
The top cited publications of GM in CVD.
| Rank | Article title | Journal | Article type | Authors | Year | Number of citations |
|---|---|---|---|---|---|---|
| 1 | Functional interactions between the gut microbiota and host metabolism | Nature | Review | Valentina Tremaroli et al. | 2012 | 2,621 |
| 2 | Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 | Science | Article | Matam Vijay-Kumar et al. | 2010 | 1,403 |
| 3 | Influence of diet on the gut microbiome and implications for human health | Journal of Translational Medicine | Review | Rasnik K Singh, et al. | 2017 | 942 |
| 4 | Gut microbiota in cardiovascular health and disease | Circulation Research | Review | W H Wilson Tang et al. | 2017 | 680 |
| 5 | Gut microbiota dysbiosis contributes to the development of hypertension | Microbiome | Article | Jing Li et al. | 2017 | 670 |
| 6 | Human oral, gut, and plaque microbiota in patients with atherosclerosis | Proceedings of the National Academy of Sciences of the United States of America | Article | Omry Koren et al. | 2011 | 639 |
| 7 | Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease | Circulation Research | Article | W.H. Wilson Tang et al. | 2015 | 635 |
| 8 | The role of the gut microbiota in energy metabolism and metabolic disease | Current Pharmaceutical Design | Review | Patrice D Cani et al. | 2009 | 613 |
| 9 | Gut microbiota in human metabolic health and disease | Nature Reviews Microbiology | Review | Yong Fan et al. | 2021 | 612 |
| 10 | The gut microbiome in atherosclerotic cardiovascular disease | Nature Communications | Article | Zhuye Jie et al. | 2017 | 552 |